| (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid |
倍他米松磷酸钠EP杂质G |
37926-75-3 |
| INDEX NAME NOT YET ASSIGNED |
NT1-O14B |
2739805-64-0 |
| 7-Keto Abiraterone Acetate |
醋酸阿比特龙7-酮杂质 |
2410075-48-6 |
| Duloxetine EP Impurity F (oxalate)Q: What is Duloxetine EP Impurity F (oxalate) Q: What is the CAS Number of Duloxetine EP Impurity F (oxalate) |
度洛西汀EP杂质F盐酸盐 |
2379325-42-3 |
| FAPI-4 |
FAPI-4 |
2374782-02-0 |
| 5-Hexynoic acid, 6-[2-(methylsulfonyl)-5-pyrimidinyl]- |
6-(2-(甲基磺酰基)嘧啶-5-基)己-5-炔酸 |
2356229-58-6 |
| Progesterone EP Impurity F |
黄体酮EP杂质F |
2257421-78-4 |
| mPEG24-acid |
mPEG24-acid |
2248203-61-2 |
| (1R,9S)-1-amino-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1,2,3,9,12,15-hexahydro-10H,13H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione methanesulfonate |
依喜替康杂质 |
2231666-58-1 |
| p-NH-Bn-oxo-DO3A |
p-NH-Bn-oxo-DO3A |
2125661-90-5 |
| Butyne-DOTA-tris(t-butyl ester) |
Butyne-DOTA-tris(t-butyl ester) |
2125661-54-1 |
| Fesoterodine Related Impurity 4 |
弗斯特罗定杂质 4 |
214601-12-4 |
| DRF-1042 |
DRF-1042 |
200619-13-2 |
| Chol-9(11)-en-24-oic acid, 3,12-dihydroxy-, (3α,5β,12α)- (9CI) |
Chol-9(11)-en-24-oic acid, 3,12-dihydroxy-, (3α,5β,12α)- (9CI) |
24637-46-5 |
| Trenbolone Acetate Process Impurity 1 |
群勃龙醋酸酯工艺杂质1 |
22841-97-0 |
| 5,7-Dimethyl-1,3-dibromoadamantane |
3,5-二甲基-1,7-二溴金刚烷 |
21912-23-2 |
| 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholan-24-oic acid |
3Α,7Α-二羟基-12-羰基-5Β-胆烷酸 |
2458-08-4 |
| (3β)-3-(Acetyloxy)pregna-5,14,16-trien-20-one |
(3β)-3-(Acetyloxy)pregna-5,14,16-trien-20-one |
2453-93-2 |
| 3-ALPHA-HYDROXY-6-KETOCHOLANIC ACID |
3Α-羟基-6K-5Β-胆甾烷-24-酸 |
2393-61-5 |
| Abiraterone Sulfate Sodium Salt |
阿比特龙硫酸钠 |
1993430-25-3 |
QQ
微信
